Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NQO2 | P16083 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.38 |
| ▸ | HTT | P42858 | 3/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | NOS3 | P29474 | 1/20 | 0.35 |
| ▸ | NOS1 | P29475 | 1/20 | 0.35 |
| ▸ | NOS2 | P35228 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | NCK1 | P16333 | 1/20 | 0.35 |
| ▸ | BACE1 | P56817 | 1/20 | 0.35 |
| ▸ | PARP1 | P09874 | 2/20 | 0.35 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6028972 | 0.91 | NQO2 (0.43) | NQO2ALDH1A1CYP1A2KDM4EHTT | |
| SCHEMBL8400256 | 0.75 | SCN10A (0.38) | ALDH1A1L3MBTL1MAPTTDP1LMNA | |
| SCHEMBL8401811 | 0.74 | PIK3CG (0.47) | ALDH1A1CYP1A2KDM4EHTTMAPT | |
| SCHEMBL8208335 | 0.74 | EGFR (0.47) | ALDH1A1KDM4EHTTMAPTLMNA | |
| SCHEMBL21477557 | 0.74 | NPC1 (0.42) | ALDH1A1KDM4EHTTL3MBTL1MAPT | |
| SCHEMBL18609103 | 0.72 | NQO2 (0.50) | NQO2ALDH1A1CYP1A2KDM4EHTT | |
| SCHEMBL30178501 | 0.72 | ALDH1A1 (0.56) | NQO2ALDH1A1CYP1A2KDM4EL3MBTL1 | |
| SCHEMBL27449 | 0.72 | ALDH1A1 (0.56) | NQO2ALDH1A1CYP1A2KDM4EL3MBTL1 | |
| SCHEMBL88615 | 0.69 | EGFR (0.41) | ALDH1A1KDM4EHTTMAPTTDP1 | |
| SCHEMBL29599774 | 0.69 | EGFR (0.41) | ALDH1A1KDM4EHTTMAPTTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11751475-B2 | Organic compound, display panel and display apparatus | XIAMEN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) | 2023-09-05 | — | — | US | disclosed |
| WO-2023275337-A1 | INHIBITORS OF TRANSGLUTAMINASES | ZEDIRA GMBH (DE) | 2023-01-05 | — | — | WO | disclosed |
| WO-2023275336-A1 | INHIBITORS OF TRANSGLUTAMINASES | ZEDIRA GMBH (DE) | 2023-01-05 | — | — | WO | disclosed |
| WO-2023275333-A1 | INHIBITORS OF TRANSGLUTAMINASES | ZEDIRA GMBH (DE) | 2023-01-05 | — | — | WO | disclosed |
| WO-2021058592-A1 | HERBICIDAL COMPOUNDS | SYNGENTA CROP PROTECTION AG (CH) | 2021-04-01 | — | — | WO | disclosed |
| EP-3556750-B1 | NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT INCLUDING SAME | LG CHEMICAL LTD (KR) | 2021-02-24 | — | — | EP | disclosed |
| EP-3556750-A1 | NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT INCLUDING SAME | LG Chem, Ltd. (KR) | 2019-10-23 | — | — | EP | disclosed |
| WO-2017040993-A1 | SMALL MOLECULE INHIBITORS OF DYRK1A AND USES THEREOF | THE ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2017-03-09 | — | — | WO | disclosed |
| US-5856325-A | REDUCING INFLAMMATION BY INHIBITING PLA2 IN A MAMMAL | BOEHRINGER MANNHEIM GMBH (DE) | 1999-01-05 | — | — | US | disclosed |
| EP-0259371-B1 | PREPARATION OF 3-DIMETHYLAMINO-7-METHYL-1,2,4-BENZOTRIAZINE-1-OXIDE AND AZAPROPAZONE | JOHN WYETH & BROTHER LIMITED (GB) | 1992-05-13 | — | — | EP | disclosed |
| EP-0259371-A1 | PREPARATION OF 3-DIMETHYLAMINO-7-METHYL-1,2,4-BENZOTRIAZINE-1-OXIDE AND AZAPROPAZONE. | ROBINS A H CO LTD (GB) | 1988-03-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11751475-B2 | Organic compound, display panel and display apparatus | C3AR1, NR0B2, NR0B1 | NQO2 3819/4885ALDH1A1 1591/4885CYP1A2 957/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.